NuGen Medical Devices Inc. (TSXV:NGMD)
Canada
· Delayed Price · Currency is CAD 0.0650
+0.0050 (8.33%)
Jun 9, 2025, 9:30 AM EDT
NuGen Medical Devices Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 6.19 | 6.95 | 0.46 | 0.13 | 1.75 | 0.27 | Upgrade
|
| Cash & Short-Term Investments | 6.19 | 6.95 | 0.46 | 0.13 | 1.75 | 0.27 | Upgrade
|
| Cash Growth | 1466.80% | 1395.51% | 253.33% | -92.49% | 556.92% | 13622.26% | Upgrade
|
| Accounts Receivable | 0.07 | 0.1 | 0.02 | 0.01 | 0.01 | 0 | Upgrade
|
| Other Receivables | 0.09 | 0.23 | 0.33 | 0.24 | 0.3 | 0.14 | Upgrade
|
| Receivables | 0.16 | 0.33 | 0.36 | 0.24 | 0.31 | 0.15 | Upgrade
|
| Inventory | 0.42 | 0.32 | 0.21 | 0.08 | 0.01 | 0.01 | Upgrade
|
| Prepaid Expenses | 0.15 | 0.15 | 0.25 | 0.12 | 0.07 | 0.04 | Upgrade
|
| Restricted Cash | 0.05 | 0.05 | 0.05 | - | - | 5.74 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.27 | Upgrade
|
| Total Current Assets | 6.96 | 7.8 | 1.33 | 0.57 | 2.15 | 6.47 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.01 | 0.03 | 0.16 | 0.02 | 0.03 | Upgrade
|
| Goodwill | 1.8 | 1.73 | 1.69 | 1.67 | 1.67 | 1.81 | Upgrade
|
| Other Intangible Assets | 3.33 | 3.36 | 3.89 | 4.45 | 5.02 | 6.26 | Upgrade
|
| Total Assets | 12.1 | 12.89 | 6.95 | 6.85 | 8.84 | 14.56 | Upgrade
|
| Accounts Payable | 0.42 | 0.67 | 0.97 | 1.44 | 0.88 | 0.82 | Upgrade
|
| Accrued Expenses | - | - | 0.07 | 0.04 | 0.35 | 0.4 | Upgrade
|
| Current Portion of Long-Term Debt | 0.61 | 0.57 | 2.14 | 0.08 | - | 2.52 | Upgrade
|
| Current Portion of Leases | - | - | 0.03 | 0.12 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 0.01 | 0.03 | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.08 | 0.08 | 0.05 | 0.04 | - | - | Upgrade
|
| Other Current Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 6.01 | Upgrade
|
| Total Current Liabilities | 1.12 | 1.34 | 3.29 | 1.73 | 1.23 | 9.75 | Upgrade
|
| Long-Term Debt | 15.21 | 17.23 | 5.72 | 7.16 | 5.61 | 4.58 | Upgrade
|
| Long-Term Leases | - | - | - | 0.04 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.18 | 0.35 | 0.92 | Upgrade
|
| Total Liabilities | 16.33 | 18.57 | 9.01 | 9.11 | 7.19 | 15.25 | Upgrade
|
| Common Stock | 23.3 | 23.22 | 21.36 | 15.07 | 14.19 | 6.81 | Upgrade
|
| Retained Earnings | -32.81 | -34.37 | -29.3 | -20.61 | -15.81 | -8.7 | Upgrade
|
| Comprehensive Income & Other | 5.28 | 5.48 | 5.88 | 3.27 | 3.28 | 1.2 | Upgrade
|
| Shareholders' Equity | -4.22 | -5.67 | -2.06 | -2.26 | 1.66 | -0.69 | Upgrade
|
| Total Liabilities & Equity | 12.1 | 12.89 | 6.95 | 6.85 | 8.84 | 14.56 | Upgrade
|
| Total Debt | 15.82 | 17.8 | 7.88 | 7.41 | 5.61 | 7.1 | Upgrade
|
| Net Cash (Debt) | -9.63 | -10.86 | -7.42 | -7.28 | -3.86 | -6.83 | Upgrade
|
| Net Cash Per Share | -0.04 | -0.05 | -0.04 | -0.08 | -0.06 | -0.13 | Upgrade
|
| Filing Date Shares Outstanding | 227.04 | 227.04 | 216.43 | 168.79 | 86.01 | 64.31 | Upgrade
|
| Total Common Shares Outstanding | 227.04 | 225.83 | 199.13 | 96.56 | 86.01 | 62.44 | Upgrade
|
| Working Capital | 5.85 | 6.47 | -1.96 | -1.16 | 0.91 | -3.28 | Upgrade
|
| Book Value Per Share | -0.02 | -0.03 | -0.01 | -0.02 | 0.02 | -0.01 | Upgrade
|
| Tangible Book Value | -9.35 | -10.75 | -7.65 | -8.38 | -5.02 | -8.76 | Upgrade
|
| Tangible Book Value Per Share | -0.04 | -0.05 | -0.04 | -0.09 | -0.06 | -0.14 | Upgrade
|
| Machinery | - | 0.03 | 0.02 | 0.02 | 0.04 | 0.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.